VEVADEQ Trademark

Trademark Overview

On Wednesday, February 9, 2022, a trademark application was filed for VEVADEQ with the United States Patent and Trademark Office. The USPTO has given the VEVADEQ trademark a serial number of 97260150. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, November 21, 2024. This trademark is owned by Pfizer Inc.. The VEVADEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

General Information

Serial Number97260150
Word MarkVEVADEQ
Filing DateWednesday, February 9, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Saturday, February 12, 2022NEW APPLICATION ENTERED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Thursday, October 20, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 5, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 5, 2023SOU EXTENSION 1 FILED
Thursday, October 5, 2023SOU EXTENSION 1 GRANTED
Saturday, October 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2024SOU EXTENSION 2 FILED
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 10, 2024SOU EXTENSION 2 GRANTED
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 21, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 21, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 25, 2024SOU EXTENSION 3 FILED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 22, 2024SOU EXTENSION 3 GRANTED
Friday, November 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

vevadeq preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone